
Sign up to save your podcasts
Or


In October last year, the FDA announced a shortage of Adderall due to manufacturing delays.
Now six months later, there is a severe shortage of not just Adderall, but similar drugs that treat ADHD. And it’s wreaking havoc on the lives of the children and adults who have the disorder.
So, what's going on and what can be done to fix the problem? Dr. David Pate, former CEO of St. Luke's Health System and current member of the Idaho Coronavirus Task Force, joined Idaho Matters to talk more about the issue.
By Boise State Public Radio4.5
102102 ratings
In October last year, the FDA announced a shortage of Adderall due to manufacturing delays.
Now six months later, there is a severe shortage of not just Adderall, but similar drugs that treat ADHD. And it’s wreaking havoc on the lives of the children and adults who have the disorder.
So, what's going on and what can be done to fix the problem? Dr. David Pate, former CEO of St. Luke's Health System and current member of the Idaho Coronavirus Task Force, joined Idaho Matters to talk more about the issue.

90,994 Listeners

43,898 Listeners

38,062 Listeners

43,528 Listeners

38,856 Listeners

9,237 Listeners

3,998 Listeners

8,454 Listeners

12,237 Listeners

6,435 Listeners

4,681 Listeners

16,399 Listeners

10 Listeners

436 Listeners

9 Listeners